Batzofin J H, Holmes S D, Gibbons W E, Buttram V C
Fertil Steril. 1985 Aug;44(2):277-9. doi: 10.1016/s0015-0282(16)48752-2.
Plasminogen activator activity in PF was assayed by the fibrinolysis method described by Strickland and Beers. In 45 patients studied, there were no discernible differences according to whether patients had endometriosis and/or pelvic adhesive disease. No differences were detected according to when in the menstrual cycle the sample of PF was obtained. These data are in concordance with a previous report and taken together suggest that there is no difference in fibrinolytic mechanisms in PF in patients with or without endometriosis and/or pelvic adhesive disease, when compared with control subjects. If such differences exist, they may be present in the tissues, per se, but are not discernible in PF.
采用Strickland和Beers描述的纤维蛋白溶解法测定PF中的纤溶酶原激活物活性。在研究的45例患者中，无论患者是否患有子宫内膜异位症和/或盆腔粘连性疾病，均未发现明显差异。根据获取PF样本时处于月经周期的时间不同，未检测到差异。这些数据与之前的一份报告一致，综合来看表明，与对照受试者相比，患有或未患有子宫内膜异位症和/或盆腔粘连性疾病的患者，其PF中的纤溶机制没有差异。如果存在这种差异，它们可能存在于组织本身，但在PF中无法辨别。
